According to the findings of this study, it remains to be established as to whether the increase in Pg abundance observed in ASCVD patients, but not in healthy subjects or patients with HeFH in primary prevention, is likely to be a consequence (almost a “marker”) rather than a cause of ASCVD. This evidence concerns the gene JUP and atherosclerosis.